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according to dose-volume histogram analysis in terms of PTV homogeneity and conformity indices (HI and CI) as well as OARs
dose, volume parameters.
Results. HI and CI of PTV showed no difference between 3DCRT and IMRT, IH: 11.6/12.5, IC: 0.95/0.96 respectively. V95 gave 97.8%
coverage for 3DCRT versus 99% for IMRT, V107 volumes were recorded as 11%, and 1.3% respectively for 3DCRT, IMRT. PTV showed
volume receiving isodose V107 is most important in 3DCRT than in IMRT. Tangential beam IMRT increased volume of ipsilateral
lung V5 average of 90% and reduced by 25% with 3DCRT. Ipsilateral V20 lung volume was 13%, 19% with IMRT and 3DCRT
respectively. Patients treated with IMRT, heart volume encompassed by 60% isodose line (30Gy) was reduced by an average of
42% (4% versus 7% with 3DCRT), mean heart dose by an average of 35% (495Gy versus 1400Gy with 3DCRT). Minimal heart dose
average 356Gy, in IMRT versus 90Gy in 3DCRT.
Conclusion. IMRT reduced irradiated volumes of heart and ipsilateral lung in high-dose areas but increased irradiated volumes in
low-dose areas in patients treated on left side.
http://dx.doi.org/10.1016/j.rpor.2013.03.087
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Introduction. The most common adjuvant radiotherapy strategy after breast conserving surgery consists of irradiation of the
whole breast followed by irradiation of the tumour bed. Overall treatment duration can be shortened, compared to conventional
radiation scheme, by integrating the boost irradiation in daily whole breast treatment.
Purpose. To compare dosimetry parameters of sequential versus integrated boost in breast adjuvant radiotherapy with 3D con-
ventional radiotherapy.
Material and methods. Retrospective dosimetry comparison of treatments delivered in 2011 in our department. Standard treatment
was delivered in 23–25 fractions (2.13–2Gy/fraction) to a total dose of 48.99–50Gy to whole breast, followed by boost irradiation
of 10, 16 or 20Gy depending on histopathological risk factors. SIB was delivered with doses of 2.30, 2.47 or 2.58Gy/fraction to
the tumour bed at the same time as the irradiation of the whole breast at 2.13 or 2Gy/fraction. Dose equivalence was calculated
according to the Linear Quadratic Model considering an alpha/beta of 4.6Gy. We compared dosimetry of both treatments taking
into account V95PTV, D2%PTV, V95PTVboost, D2%PTVboost, D2%whole body, V20Lung and Median Dose to the heart (in left
breasts) Statistic analysis performing T student with SPPS programme V10.
Results. 63 women were treated in our department in 2011 with adjuvant radiotherapy to whole breast + sequential boost, while
57 women were treated in the same period with SIB. Mean difference (MD) for PTV95=0.20 (95%CI: −1.25, 1.67); MD PTVD2%=0.69
(95%CI:−0.13, 1.51):MDPTVboost95=0.86 (95%CI:−0.77, 2.49);MDPTVD2%=−0.001 (95%CI:−0.53, 0.52);MDD2%whole body=1.55
(95%CI: −0.29, 3.41); MD V20Lung=1.67 (95%CI: −0.93, 4.28); MD DMediaHeart = 0.296 (95%CI: −1.25, 1.84).
Conclusions. The mean differences of the dosimetry parameters analyzed were not signiﬁcant with a conﬁdence interval of 95%.
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Introduction and objective. The aim of this work is to assess the accuracy of the dose calculation performed with a commercial
TPS for breast IMRT radiotherapy in presence of metallic expanders. A Monte Carlo method is used as gold standard for this
evaluation.
Materials and methods. Three breast patients with metallic expanders (model McGhan Style 150) were enrolled in this study. A
dynamic IMRT plan consisting of two tangencial ﬁelds was planned for each case using Eclipse TPS (v 10.0). The AAA algo-
rithm was used for 6MV beams. On the other hand, EGSnrc Monte Carlo algorithm was used to obtain the dose distribution for
each plan generated previously by the Eclipse TPS. MC simulations were performed using the BEAMnrc code for the treatment-
head simulation and the DOSXYZnrc code for the patient dose calculation. Dose volume histogram (DVH) for PTV was the
metric used to evaluate the accuracy of the AAA algorithm to calculate clinical dose distributions in the presence of a tissue
expander.
Results. Small dose differences (<2%) for PTV DVH were found between AAA and MC algorithms. Eclipse AAA algorithm overes-
timates the mean target dose about 2%.
Conclusions. Eclipse TPS (AAA algorithm) is able to compute reliable dose distribution when an expander is placed in the breast.
The clinical impact of the expander on the target dosage seems to be negligible.
